Company Overview and News
De Grey Mining has raised $6 million, with ASX-listed DGO Gold investing $5 million in the placement, to expand exploration work at the company’s Pilbara gold project.
DGO Gold will make a strategic investment in Pilbara gold counterpart, De Grey Mining, helping it to advance assets in the region.
De Grey Mining Limited (ASX:DEG) is undertaking a heritage survey over three conglomerate gold targets in the Pilbara region of Western Australia.
De Grey Mining Limited (ASX:DEG) has a wide range of projects but in terms of generating medium-term cash flow, the focus is on its Pilbara Gold Project.
De Grey Mining has announced the upgrade of conglomerate-style gold hosting at its Pilbara gold project near Port Hedland, Western Australia following the discovery of nuggets during orientation sampling.
De Grey Mining Limited (ASX:DEG) has commenced drilling at the Mt Berghaus gold deposit within the 1.2 million ounce Pilbara Gold Project, near Port Hedland, Western Australia.
Tando Resources Ltd (ASX:TNO) has intersected high-grade copper and zinc at the Quartz Bore project in the Pilbara region of Western Australia.
Gold aspirant De Grey Mining has executed a deal to acquire the Indee Gold project in the Pilbara from Northwest Non-Ferrous Australian Mining (NNAM) for $15 million.
Local explorer De Grey Mining will proceed with a $15 million acquisition of the Indee gold project, located near Port Hedland, from private company Northwest Nonferrous Mining Australia.
Canadian businessman and Kirkland Lake Gold chairman Eric Sprott has been closely involved in the development of the gold mining industry on both sides of Australia this year.
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES
SYDNEY, Nov 30 (Reuters) - Canada-based Kirkland Lake Gold listed its shares on the Australia bourse on Thursday after investing millions of dollars and joining dozens of other prospectors in a modern-day gold rush.
SYDNEY (Reuters) - Canada-based Kirkland Lake Gold will list its shares on the Australia bourse on Thursday after investing millions of dollars and joining dozens of other prospectors in a modern-day gold rush.
Explorer Kairos Minerals is launching gold drilling at Roe Hills as its second phase of operation following positive initial aircore drilling cobalt results, which are now being dispatched for assaying.
Gold explorer Kalamazoo Resources has discovered two nugget occurrences at The Sisters project in the Pilbara region of Western Australia.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...